Vincristine-doxorubicin-dexamethasone (VAD)

What is Vincristine-doxorubicin-dexamethasone (VAD)?

Vincristine-doxorubicin-dexamethasone, also known as VAD, is a regimen that may be used for the treatment of multiple myeloma. It contains the anticancer agents vincristine and doxorubicin along with dexamethasone, a corticosteroid.

Save up to 80% off your prescriptions!

How do members experience Vincristine-doxorubicin-dexamethasone (VAD)?

Top 5 reported purposes & perceived effectiveness

Purpose Patients Evaluations Perceived Effectiveness
Multiple myeloma 65 0
Bone marrow transplant 1 0
Breast cancer 1 0
Ewing's sarcoma of bone 1 1

Common side effects

Side effect Patients Percentage
Constipation 1
Fatigue 1
Nausea 1
Neutropenia (low neutrophils) 1
Orange colored urine 1
Sensory sensitivity 1

Side effect severity

Side effects as an overall problem
Severity Evaluations Percentage
Severe 0
Moderate 1
Mild 1
None 0

Member evaluations

depressed_to_death

evaluated on Feb 01, 2010

  • Perceived effectiveness for Other: Can't tell
  • Side effects: Mild
Learn more about our community’s experience with Vincristine-doxorubicin-dexamethasone (VAD)

What are people saying about Vincristine-doxorubicin-dexamethasone (VAD)?

72

72

members have reported taking Vincristine-doxorubicin-dexamethasone (VAD)

Join the conversation and connect with people who have taken Vincristine-doxorubicin-dexamethasone (VAD)
Last updated:

Save up to 80% off your prescriptions!

ADVERTISEMENT

ADVERTISEMENT